Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model
Therapeutic vaccination as a treatment option for HPV-induced cancers is actively pursued because the two HPV proteins E6 and E7 represent ideal targets for immunotherapy, as they are non-self and expressed in all tumor stages. MHC-humanized mice are valuable tools for the study of therapeutic cance...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
OncoImmunology
Year: 2018, Volume: 8, Issue: 1 |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2018.1524694 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1080/2162402X.2018.1524694
|
| Author Notes: | Sebastian Kruse, Marleen Büchler, Philipp Uhl, Max Sauter, Philipp Scherer, Tammy C.T. Lan, Samantha Zottnick, Alexandra Klevenz, Ruwen Yang, Frank Rösl, Walter Mier & Angelika B. Riemer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1666836508 | ||
| 003 | DE-627 | ||
| 005 | 20220816165505.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190605r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/2162402X.2018.1524694 |2 doi | |
| 035 | |a (DE-627)1666836508 | ||
| 035 | |a (DE-599)KXP1666836508 | ||
| 035 | |a (OCoLC)1341227550 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Kruse, Sebastian |e VerfasserIn |0 (DE-588)1184315884 |0 (DE-627)1663472513 |4 aut | |
| 245 | 1 | 0 | |a Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model |c Sebastian Kruse, Marleen Büchler, Philipp Uhl, Max Sauter, Philipp Scherer, Tammy C.T. Lan, Samantha Zottnick, Alexandra Klevenz, Ruwen Yang, Frank Rösl, Walter Mier & Angelika B. Riemer |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 29 October 2018 | ||
| 500 | |a Gesehen am /05.06.2019 | ||
| 520 | |a Therapeutic vaccination as a treatment option for HPV-induced cancers is actively pursued because the two HPV proteins E6 and E7 represent ideal targets for immunotherapy, as they are non-self and expressed in all tumor stages. MHC-humanized mice are valuable tools for the study of therapeutic cancer vaccines - given the availability of a suitable tumor model. Here, we present for the first time an HPV16 tumor model suitable for fully MHC-humanized A2.DR1 mice, PAP-A2 cells, which in contrast to existing HPV16 tumor models allows the exclusive study of HLA-A2- and DR1-mediated immune responses, without any interfering murine MHC-presented epitopes. We used several HPV16 epitopes that were shown to be presented on human cervical cancer cells by mass spectrometry for therapeutic anti-tumor vaccination in the new tumor model. All epitopes were immunogenic when rendered amphiphilic by incorporation into a molecule containing stearic acids. Prophylactic and therapeutic vaccination experiments with the epitope E7/11-19 demonstrated that effective immune responses could be induced with these vaccination approaches in A2.DR1 mice. Interestingly, the combination of E7/11-19 with other immunogenic HPV16 E6/E7 epitopes caused a reduction of vaccine efficacy, although all tested combinations resulted in a survival benefit. In summary, we present the first HPV16 tumor model for exclusive studies of HLA-A2-mediated anti-HPV tumor immune responses and show anti-tumor efficacy of minimal epitope vaccines. | ||
| 534 | |c 2018 | ||
| 650 | 4 | |a A2.DR1 | |
| 650 | 4 | |a Cancer immunotherapy | |
| 650 | 4 | |a HLA-humanized mouse model | |
| 650 | 4 | |a human papillomavirus (HPV) | |
| 650 | 4 | |a PAP-A2 | |
| 650 | 4 | |a therapeutic vaccination | |
| 700 | 1 | |a Büchler-Schäff, Marleen |d 1989- |e VerfasserIn |0 (DE-588)1187858501 |0 (DE-627)1666834947 |4 aut | |
| 700 | 1 | |a Uhl, Philipp |e VerfasserIn |0 (DE-588)1112349391 |0 (DE-627)866420797 |0 (DE-576)476575230 |4 aut | |
| 700 | 1 | |a Sauter, Max |e VerfasserIn |0 (DE-588)1103516507 |0 (DE-627)86126813X |0 (DE-576)470642033 |4 aut | |
| 700 | 1 | |a Yang, Ruwen |e VerfasserIn |0 (DE-588)1187858854 |0 (DE-627)1666836060 |4 aut | |
| 700 | 1 | |a Mier, Walter |d 1966- |e VerfasserIn |0 (DE-588)12029026X |0 (DE-627)69653567X |0 (DE-576)292141599 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 8(2019,1) Artikel-Nummer e1524694, ? Seiten |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model |
| 773 | 1 | 8 | |g volume:8 |g year:2019 |g number:1 |a Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model |
| 856 | 4 | 0 | |u https://doi.org/10.1080/2162402X.2018.1524694 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190605 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 12029026X |a Mier, Walter |m 12029026X:Mier, Walter |d 910000 |d 911400 |e 910000PM12029026X |e 911400PM12029026X |k 0/910000/ |k 1/910000/911400/ |p 11 | ||
| 998 | |g 1187858854 |a Yang, Ruwen |m 1187858854:Yang, Ruwen |d 140000 |e 140000PY1187858854 |k 0/140000/ |p 9 | ||
| 998 | |g 1103516507 |a Sauter, Max |m 1103516507:Sauter, Max |d 140000 |e 140000PS1103516507 |k 0/140000/ |p 4 | ||
| 998 | |g 1112349391 |a Uhl, Philipp |m 1112349391:Uhl, Philipp |d 140000 |e 140000PU1112349391 |k 0/140000/ |p 3 | ||
| 998 | |g 1187858501 |a Büchler-Schäff, Marleen |m 1187858501:Büchler-Schäff, Marleen |d 140000 |e 140000PB1187858501 |k 0/140000/ |p 2 | ||
| 998 | |g 1184315884 |a Kruse, Sebastian |m 1184315884:Kruse, Sebastian |d 140000 |e 140000PK1184315884 |k 0/140000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1666836508 |e 3481453515 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Published online: 29 October 2018","Gesehen am /05.06.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model","title_sort":"Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model"}],"person":[{"display":"Kruse, Sebastian","family":"Kruse","role":"aut","given":"Sebastian"},{"family":"Büchler-Schäff","given":"Marleen","role":"aut","display":"Büchler-Schäff, Marleen"},{"family":"Uhl","role":"aut","given":"Philipp","display":"Uhl, Philipp"},{"role":"aut","given":"Max","family":"Sauter","display":"Sauter, Max"},{"display":"Yang, Ruwen","family":"Yang","given":"Ruwen","role":"aut"},{"family":"Mier","given":"Walter","role":"aut","display":"Mier, Walter"}],"relHost":[{"pubHistory":["1.2012 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 13.12.2022"],"titleAlt":[{"title":"Onco Immunology"}],"title":[{"title_sort":"OncoImmunology","title":"OncoImmunology"}],"disp":"Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor modelOncoImmunology","recId":"683365428","part":{"text":"8(2019,1) Artikel-Nummer e1524694, ? Seiten","volume":"8","year":"2019","issue":"1"},"id":{"eki":["683365428"],"issn":["2162-402X"],"zdb":["2645309-5"]},"origin":[{"dateIssuedDisp":"2012-","publisher":"Taylor & Franics ; Landes Bioscience","dateIssuedKey":"2012","publisherPlace":"Abingdon ; Austin, Tex."}]}],"recId":"1666836508","name":{"displayForm":["Sebastian Kruse, Marleen Büchler, Philipp Uhl, Max Sauter, Philipp Scherer, Tammy C.T. Lan, Samantha Zottnick, Alexandra Klevenz, Ruwen Yang, Frank Rösl, Walter Mier & Angelika B. Riemer"]},"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"id":{"doi":["10.1080/2162402X.2018.1524694"],"eki":["1666836508"]}} | ||
| SRT | |a KRUSESEBASTHERAPEUTI2019 | ||